FGFR redundancy limits the efficacy of FGFR4-selective inhibitors in hepatocellular carcinoma.

Tao Z, Cui Y, Xu X, Han T
Proc Natl Acad Sci U S A. 2022 Oct 4;119(40):e2208844119. doi: 10.1073/pnas.2208844119. Epub 2022 Sep 30. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.